These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36798787)
1. Prognostic Significance of the CXCLs and Its Impact on the Immune Microenvironment in Ovarian Cancer. Gu C; Xiong X; Liu W Dis Markers; 2023; 2023():5223657. PubMed ID: 36798787 [TBL] [Abstract][Full Text] [Related]
2. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma. Zhou X; Guo S; Shi Y Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the role of CXCL family members in clear cell renal cell carcinoma. Qiu J; Wang Z; Zhang P; Xu Y; Yang T; Xia Q Curr Cancer Drug Targets; 2023 Aug; ():. PubMed ID: 37641996 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer. Li S; Zou D; Liu Z Front Pharmacol; 2023; 14():1127557. PubMed ID: 36969851 [No Abstract] [Full Text] [Related]
6. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
7. Transcriptional Expressions of CXCL9/10/12/13 as Prognosis Factors in Breast Cancer. Li Y; Liang M; Lin Y; Lv J; Chen M; Zhou P; Fu F; Wang C J Oncol; 2020; 2020():4270957. PubMed ID: 32963527 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor. Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149 [TBL] [Abstract][Full Text] [Related]
9. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer. Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884 [TBL] [Abstract][Full Text] [Related]
10. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers. Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L Front Immunol; 2019; 10():6. PubMed ID: 30761122 [No Abstract] [Full Text] [Related]
11. The Role of CXCL13 and CXCL9 in Early Breast Cancer. Razis E; Kalogeras KT; Kotsantis I; Koliou GA; Manousou K; Wirtz R; Veltrup E; Patsea H; Poulakaki N; Dionysopoulos D; Pervana S; Gogas H; Koutras A; Pentheroudakis G; Christodoulou C; Linardou H; Pavlakis K; Koletsa T; Pectasides D; Zagouri F; Fountzilas G Clin Breast Cancer; 2020 Feb; 20(1):e36-e53. PubMed ID: 31699671 [TBL] [Abstract][Full Text] [Related]
12. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10. Li W; Ma JA; Sheng X; Xiao C World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429 [TBL] [Abstract][Full Text] [Related]
13. [Relationships between decreased LAMC3 and poor prognosis in ovarian cancer]. Lei SM; Liu X; Xia LP; Ke Y; Wei LW; Li L; Yin FJ Zhonghua Fu Chan Ke Za Zhi; 2021 Jul; 56(7):489-497. PubMed ID: 34304441 [No Abstract] [Full Text] [Related]
14. Integrated analysis of prognostic immune-related genes in the tumor microenvironment of ovarian cancer. Wang J; Su X; Wang C; Xu M Ann Transl Med; 2022 Jan; 10(2):91. PubMed ID: 35282097 [TBL] [Abstract][Full Text] [Related]
15. Molecular Analysis of Prognosis and Immune Infiltration of Ovarian Cancer Based on Homeobox D Genes. Chen B; Gao C; Wang H; Sun J; Han Z Comput Math Methods Med; 2022; 2022():3268386. PubMed ID: 36213580 [TBL] [Abstract][Full Text] [Related]
16. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines. Sun X; Chen Q; Zhang L; Chen J; Zhang X Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer. Diao B; Yang P Pathol Oncol Res; 2021; 27():1609855. PubMed ID: 34512203 [TBL] [Abstract][Full Text] [Related]
18. Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes. Karapetyan L; AbuShukair HM; Li A; Knight A; Al Bzour AN; MacFawn IP; Thompson ZJ; Chen A; Yang X; Dadey R; Karunamurthy A; De Stefano DV; Sander C; Kunning SR; Najjar YG; Davar D; Luke JJ; Gooding W; Bruno TC; Kirkwood JM; Storkus WJ Front Immunol; 2023; 14():1171978. PubMed ID: 37435077 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer. Zhang P; Su T; Zhang S J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143 [TBL] [Abstract][Full Text] [Related]
20. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification. Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]